Anemia
News
Combo worsens platelet recovery in MDS
Results from the phase 3 SUPPORT trial suggest there is no role for the combination of eltrombopag and azacitidine in patients with intermediate-...
News
FDA clears portable hematology analyzer
The U.S.
News
Denosumab fights osteoporosis in TDT patients
Denosumab can be effective against osteoporosis caused by transfusion-dependent thalassemia (TDT), according to research published in Blood...
Conference Coverage
Primary care needs pile up for sickle cell patients
BETHESDA, MD. – With people often surviving into middle age with SCD, physicians need to keep in mind the routine complications of aging in these...
Conference Coverage
Sickle cell disease gene therapy seen advancing
BETHESDA, MD. – NIH conference highlights experimental gene therapies for SCD and thalassemia, with further updates on this work slated for ASH’s...
News
Links between SCT and adverse outcomes
Although sickle cell trait (SCT) has been linked to adverse clinical outcomes in multiple studies, only a handful of associations have strong...
From the Journals
Few clinical outcomes convincingly linked to sickle cell trait
The systematic review showed evidence to support sickle cell trait as a risk factor for proteinuria and chronic kidney disease.
News
Lnk deficiency boosts HSC replication in Fanconi anemia
A novel approach can restore hematopoietic stem cell (HSC) function in Fanconi anemia (FA), according to preclinical research published in Nature...
News
Inhibitor receives orphan designation for ITP
The U.S.
News
‘Intense’ end-of-life care may be common in HSCT recipients
Patients who die within a year of allogeneic hematopoietic stem cell transplant (HSCT) tend to receive “medically intense” end-of-life care, an...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.